Jeff Ajer
2020
Compensation breakdown
| Non-Equity Incentive Plan | $402,600 |
|---|---|
| Option Awards | $788,869 |
| Salary | $628,654 |
| Stock Awards | $2,696,310 |
| Other | $20,003 |
| Total | $4,536,436 |
Ajer received $2.7M in stock awards, accounting for 59% of the total pay in 2020.
Ajer also received $402.6K in non-equity incentive plan, $788.9K in option awards, $628.7K in salary and $20K in other compensation.
Rankings
In 2020, Jeff Ajer's compensation ranked 2,476th out of 13,090 executives tracked by ExecPay. In other words, Ajer earned more than 81.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,476 out of 13,090 | 81st |
Division Manufacturing | 947 out of 5,617 | 83rd |
Major group Chemicals And Allied Products | 340 out of 2,248 | 85th |
Industry group Drugs | 291 out of 1,948 | 85th |
Industry Pharmaceutical Preparations | 210 out of 1,453 | 86th |
Pay ratio
| Jeff Ajer's Pay | $4,536,436 |
|---|---|
| Median Employee's Pay | $181,141 |
| Pay Ratio | 25to 1 |
In 2020, the annual total compensation of Jeff Ajer was $4,536,436.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.
The ratio of Jeff Ajer's pay to the pay of median employee was therefore 25 to one.
Ajer's colleagues
We found six more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2020.
2020
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2020
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2020
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
2020
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
2020
Robert Baffi
BioMarin Pharmaceutical
Former President of Global Manufacturing and Technical Operations
2020
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019